Etanercept in the treatment of SAPHO syndrome

Int J Dermatol. 2015 Jun;54(6):e206-8. doi: 10.1111/ijd.12675. Epub 2014 Sep 10.

Authors

Luis-Carlos Sáez-Martín¹, Susana Gómez-Castro², Concepción Román-Curto³, Irene Palacios-Álvarez³, Emilia Fernández-López³

Affiliations

¹ Department of Dermatology, University General Hospital Gregorio Marañón of Madrid, Madrid, Spain.
² Department of Rheumatology, University Hospital of Salamanca, Salamanca, Spain.
³ Department of Dermatology, University Hospital of Salamanca, Salamanca, Spain.

PMID: 25209928
DOI: 10.1111/ijd.12675

No abstract available

Publication types

Case Reports

MeSH terms

Acquired Hyperostosis Syndrome / drug therapy*
Adult
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Etanercept / therapeutic use*
Female
Humans

Substances

Anti-Inflammatory Agents, Non-Steroidal
Etanercept